Dan Gabriel Duda

Closest collaborators

The 25 strongest of 63 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Lance L. Munn · 1 shared grant, 2025 · strength 1.07
   • Grant Vascularized tumor explants for drug testing R01CA247441↗
2. Rakesh K. Jain · 4 shared papers, 2014–2025 · strength 0.48
   • Paper IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against… DOI 10.1136/jitc-2024-011404↗
   • Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
   • Paper Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanc… DOI 10.1001/jamaoncol.2019.0892↗
3. Nilesh P. Talele · 3 shared papers, 2019–2025 · strength 0.45
   • Paper IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against… DOI 10.1136/jitc-2024-011404↗
   • Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
   • Paper Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanc… DOI 10.1001/jamaoncol.2019.0892↗
4. Mikaël J. Pittet · 2 shared papers, 2023–2025 · strength 0.38
   • Paper IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against… DOI 10.1136/jitc-2024-011404↗
   • Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
5. Dai Fukumura · 2 shared papers, 2023–2025 · strength 0.38
   • Paper IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against… DOI 10.1136/jitc-2024-011404↗
   • Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
6. Simona Dima · 4 shared papers, 2012–2022 · strength 0.35
   • Paper Using Molecular Subtyping of Pancreatic Ductal Adenocarcinoma for Multimodal Treatment Selection in Resectable Disease. DOI 10.21614/chirurgia.2772↗
   • Paper Epigenetic Silencing of GNMT Gene in Pancreatic Adenocarcinoma. PMID 25560641↗
   • Paper Characterization of functional transient receptor potential melastatin 8 channels in human pancreatic ductal adenocarci… DOI 10.1097/mpa.0000000000000106↗
7. Irinel Popescu · 4 shared papers, 2012–2022 · strength 0.35
   • Paper Using Molecular Subtyping of Pancreatic Ductal Adenocarcinoma for Multimodal Treatment Selection in Resectable Disease. DOI 10.21614/chirurgia.2772↗
   • Paper Epigenetic Silencing of GNMT Gene in Pancreatic Adenocarcinoma. PMID 25560641↗
   • Paper Characterization of functional transient receptor potential melastatin 8 channels in human pancreatic ductal adenocarci… DOI 10.1097/mpa.0000000000000106↗
8. Traian Dumitraşcu · 2 shared papers, 2012–2022 · strength 0.26
   • Paper Using Molecular Subtyping of Pancreatic Ductal Adenocarcinoma for Multimodal Treatment Selection in Resectable Disease. DOI 10.21614/chirurgia.2772↗
   • Paper An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcino… DOI 10.1097/mpa.0b013e3182546e13↗
9. Theodore Sunki Hong · 3 shared papers, 2014–2023 · strength 0.24
   • Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
   • Paper Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanc… DOI 10.1001/jamaoncol.2019.0892↗
   • Paper A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine f… DOI 10.1016/j.ijrobp.2014.03.034↗
10. Yves Boucher · 3 shared papers, 2014–2023 · strength 0.24
    • Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
    • Paper Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanc… DOI 10.1001/jamaoncol.2019.0892↗
    • Paper A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine f… DOI 10.1016/j.ijrobp.2014.03.034↗
11. David P. Ryan · 3 shared papers, 2014–2023 · strength 0.24
    • Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
    • Paper Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanc… DOI 10.1001/jamaoncol.2019.0892↗
    • Paper A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine f… DOI 10.1016/j.ijrobp.2014.03.034↗
12. Jennifer Yon-Li Wo · 3 shared papers, 2014–2023 · strength 0.24
    • Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
    • Paper Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanc… DOI 10.1001/jamaoncol.2019.0892↗
    • Paper A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine f… DOI 10.1016/j.ijrobp.2014.03.034↗
13. Carlos F. Fernandez-del Castillo · 2 shared papers, 2014–2023 · strength 0.18
    • Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
    • Paper A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine f… DOI 10.1016/j.ijrobp.2014.03.034↗
14. Masahiro Iseki · 1 shared paper, 2023 · strength 0.15
    • Paper Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment. DOI 10.1111/cas.15952↗
15. Masamichi Mizuma · 1 shared paper, 2023 · strength 0.15
    • Paper Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment. DOI 10.1111/cas.15952↗
16. Keiko Nakayama · 1 shared paper, 2023 · strength 0.15
    • Paper Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment. DOI 10.1111/cas.15952↗
17. Shuichi Aoki · 1 shared paper, 2023 · strength 0.15
    • Paper Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment. DOI 10.1111/cas.15952↗
18. Koetsu Inoue · 1 shared paper, 2023 · strength 0.15
    • Paper Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment. DOI 10.1111/cas.15952↗
19. Ryosuke Kashiwagi · 1 shared paper, 2023 · strength 0.15
    • Paper Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment. DOI 10.1111/cas.15952↗
20. Michiaki Unno · 1 shared paper, 2023 · strength 0.15
    • Paper Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment. DOI 10.1111/cas.15952↗
21. Mari A. Mino-Kenudson · 1 shared paper, 2023 · strength 0.14
    • Paper Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Can… DOI 10.1158/1078-0432.ccr-22-1630↗
22. Lawrence Scott Blaszkowsky · 2 shared papers, 2014–2019 · strength 0.09
    • Paper Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanc… DOI 10.1001/jamaoncol.2019.0892↗
    • Paper A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine f… DOI 10.1016/j.ijrobp.2014.03.034↗
23. Eunice Lee Kwak · 2 shared papers, 2014–2019 · strength 0.09
    • Paper Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanc… DOI 10.1001/jamaoncol.2019.0892↗
    • Paper A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine f… DOI 10.1016/j.ijrobp.2014.03.034↗
24. JulioIglesias Garcia · 1 shared paper, 2019 · strength 0.07
    • Paper Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in pa… DOI 10.4103/eus.eus_16_19↗
25. Michael Hocke · 1 shared paper, 2019 · strength 0.07
    • Paper Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in pa… DOI 10.4103/eus.eus_16_19↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.